Gracemore Nursing And Rehab | |
2708 Lee Street, Brunswick, Georgia 31520 | |
(912) 265-6771 | |
Name | Gracemore Nursing And Rehab |
---|---|
Location | 2708 Lee Street, Brunswick, Georgia |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 60 |
Occupancy Rate | 51.67% |
Medicare ID (CCN) | 115554 |
Legal Business Name | Gracemore, Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1477542991 |
Organization Name | GRACEMORE, LLC |
Address | 2708 Lee St, Brunswick, GA 31520 |
Phone Number | 912-265-6771 |
News Archive
A new study examines the origin and continuing evolution of SARS-CoV-2 in the human and animal co-hosts in an attempt to help prepare for future destructive outbreaks.
Agenus Inc. announced today that the company has entered into a collaboration and license agreement with Merck, known as MSD outside the United States and Canada, through a subsidiary, for the discovery and development of therapeutic antibodies to immune checkpoints for the treatment of cancer. Under the terms of the agreement, Agenus will discover and optimize fully human antibodies against two undisclosed Merck checkpoint targets using the 4-Antibody Retrocyte Display® platform.
Asthma is a serious public health problem. An estimated 300 million people worldwide suffer from this sometimes deadly lung disease, a number expected to increase to 400 million by 2025. One well-established risk factor for asthma is having a mother who smoked during her pregnancy.
Regency Therapeutics, a newly established division of Luitpold Pharmaceuticals, Inc., and its co-promotion partner Daiichi Sankyo, Inc., announced today that they have launched SPRIX® (ketorolac tromethamine) Nasal Spray and that it is now commercially available.
It is standard practice in Swedish delivery rooms to use oxytocin to stimulate a labour that has been slow to start or has grind to a halt for a few hours. However, it is also fine to wait for a further three hours in first-time mothers, reveals a thesis from the University of Gothenburg, Sweden.
› Verified 9 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
A new study examines the origin and continuing evolution of SARS-CoV-2 in the human and animal co-hosts in an attempt to help prepare for future destructive outbreaks.
Agenus Inc. announced today that the company has entered into a collaboration and license agreement with Merck, known as MSD outside the United States and Canada, through a subsidiary, for the discovery and development of therapeutic antibodies to immune checkpoints for the treatment of cancer. Under the terms of the agreement, Agenus will discover and optimize fully human antibodies against two undisclosed Merck checkpoint targets using the 4-Antibody Retrocyte Display® platform.
Asthma is a serious public health problem. An estimated 300 million people worldwide suffer from this sometimes deadly lung disease, a number expected to increase to 400 million by 2025. One well-established risk factor for asthma is having a mother who smoked during her pregnancy.
Regency Therapeutics, a newly established division of Luitpold Pharmaceuticals, Inc., and its co-promotion partner Daiichi Sankyo, Inc., announced today that they have launched SPRIX® (ketorolac tromethamine) Nasal Spray and that it is now commercially available.
It is standard practice in Swedish delivery rooms to use oxytocin to stimulate a labour that has been slow to start or has grind to a halt for a few hours. However, it is also fine to wait for a further three hours in first-time mothers, reveals a thesis from the University of Gothenburg, Sweden.
› Verified 9 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $650 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 23.89 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.78 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 34.37 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.33 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 12.15 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.4 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.4 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 19.81 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 88.57 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 12.96 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 35.27 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 33.04 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 11.11 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 77.24 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 93.53 | 82.93 |
News Archive
A new study examines the origin and continuing evolution of SARS-CoV-2 in the human and animal co-hosts in an attempt to help prepare for future destructive outbreaks.
Agenus Inc. announced today that the company has entered into a collaboration and license agreement with Merck, known as MSD outside the United States and Canada, through a subsidiary, for the discovery and development of therapeutic antibodies to immune checkpoints for the treatment of cancer. Under the terms of the agreement, Agenus will discover and optimize fully human antibodies against two undisclosed Merck checkpoint targets using the 4-Antibody Retrocyte Display® platform.
Asthma is a serious public health problem. An estimated 300 million people worldwide suffer from this sometimes deadly lung disease, a number expected to increase to 400 million by 2025. One well-established risk factor for asthma is having a mother who smoked during her pregnancy.
Regency Therapeutics, a newly established division of Luitpold Pharmaceuticals, Inc., and its co-promotion partner Daiichi Sankyo, Inc., announced today that they have launched SPRIX® (ketorolac tromethamine) Nasal Spray and that it is now commercially available.
It is standard practice in Swedish delivery rooms to use oxytocin to stimulate a labour that has been slow to start or has grind to a halt for a few hours. However, it is also fine to wait for a further three hours in first-time mothers, reveals a thesis from the University of Gothenburg, Sweden.
› Verified 9 days ago
Senior Care Center - Brunswick Location: 2611 Wildwood Drive, Brunswick, Georgia 31520 Phone: (912) 265-8528 |